Association of the 719Arg variant of KIF6 with both increased risk of coronary events and with greater response to statin therapy.
Olga
O
Iakoubova
James
J
Shepherd
Frank
F
Sacks
D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001120:Arginine; D003324:Coronary Artery Disease / Q000235:genetics* / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D016547:Kinesins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D001120:Arginine; C526774:KIF6 protein, human; D016547:Kinesins